Table 3. Demographic parameters of the glaucoma cohort.

N		52
Age (years)		48.0±18.8
Gender (male/female)		36 (69.2%) / 16 (30.8%)
Pathogenic virus	RV	11 (21.2%) (AI: 24.31±45.71)
	CMV	32 (61.5%) (AI: 30.07±81.57)
	HSV	5 (9.6%) (AI: 5.24±2.32)
	VZV	3 (5.8%) (AI:3.15±0.13)
	MV	1 (1.9%) (AI: 2.99)
Before AC stab incision	Side (right/left)	31 (59.6%) / 21 (40.4%)
	Involvement (unilateral/bilateral)	50 (96.2%) / 2 (3.8%)
	Course of disease (acute/chronic)	38 (73.1%) / 14 (26.9%)
	Previous keratitis	9 (17.3%)
	Visual acuity (logMAR)	0.16±0.32
	IOP	29.79±10.66 mmHg
	Local therapy	2.08±0.81
	Systemic glaucoma therapy (acetazolamid)	18 (34.6%)
	Steroid therapy (local)	37 (71.2%)
Clinical findings	Conjunctival redness	28 (53.8%)
	Corneal edema	1 (1.9%)
	Keratic precipitates	42 (80.8%)
	Character of precipitates (granulomatous/fine/pigmented /not documented/nothing)	8 (15.4%) / 22 (42.3%) / 7 (13.5%) / 6 (11.5%) / 9 (17.3%)
	Location of precipitates (Arlt´s triangle/diffuse scattered/endotheliitis/not documented)	8 (15.4%) / 27 (51.9%) / 2 (3.8%) / 15 (28.8%)
	Cells in anterior chamber	18 (34.6%)
	Hypopyon	0 (0%)
	Fibrin	4 (7.7%)
	Iris Synechiae	2 (3.8%)
	Irisatrophy	6 (11.5%)
	Heterochromia	8 (15.4%)
	Lens (corticonuclear cataract or subcapsular posterior cataract/ pseudophacic/ clear lens	14 (26.9%) /11 (21.2%) / 27 (51.9%)
	Vitreous Haze (0/+1/+2/+3)	47 (90.4%) / 4 (7.7%) / 1 (1.9%) / 0 (0%)
	Retinal infiltrates	0 (0%)
	Macula edema	0 (0%)
Recurrence	recurrence (no /yes /not documented)	13 (25.1%) / 37 (71.1%) / 2 (3.8%)

AC = anterior chamber, CMV = cytomegalovirus, HSV = herpes simplex virus, MV = multiple virus, RV = rubella, VZV = varicella-zoster virus, IOP = intraocular pressure